Samantha Gnanasegaram, MD | |
36 Clinton St, Concord, NH 03301-2359 | |
(603) 271-5485 | |
Not Available |
Full Name | Samantha Gnanasegaram |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 36 Clinton St, Concord, New Hampshire |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023440252 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 18110 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Samantha Gnanasegaram, MD 36 Clinton St, Concord, NH 03301-2359 Ph: (603) 271-5485 | Samantha Gnanasegaram, MD 36 Clinton St, Concord, NH 03301-2359 Ph: (603) 271-5485 |
News Archive
Food and water are the essential needs of the body to survive. The body requires adequate amounts of vitamins and nutrients to function properly. People with limited access to food are 10 to 37 percent more likely to have a premature death, according to a new study.
Novavax, Inc. announced that its virus-like particle (VLP) influenza vaccine has been named by the editors of R&D Directions magazine as one of the top "100 great investigational drugs in development" today. In its tenth annual list of promising clinical compounds, R&D Directions cited Novavax's virus-like-particle technology as a promising new approach to producing vaccines to prevent seasonal, H1N1 and avian influenza. The list reflects the current interests of industry observers and analysts and is described in the magazine's March 2011 issue.
Children with an aggressive form of cancer are being given new hope in a world-first trans-Atlantic clinical trial that will test a new three-part treatment.
Boehringer Ingelheim Pharmaceuticals announced today that it has made more than $350 million worth of capital investments throughout its U.S. operations this year, in order to further bolster its drug discovery, development and manufacturing capabilities.
Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival.
› Verified 2 days ago
Dr. Alexandra I Kuftinec, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-227-7000 | |
Nicole S Ross, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Pembroke Rd, Concord, NH 03301 Phone: 603-225-0123 | |
Dr. George William Luhrmann, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 36 Clinton St, Concord, NH 03301 Phone: 603-271-5300 Fax: 603-271-5395 | |
Olga Zhalkovska, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-227-7000 | |
R. Joffree Barrnett, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 36 Clinton St, Concord, NH 03301 Phone: 603-271-5907 Fax: 603-271-5962 | |
Dr. Mark Anthony Lombardo, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6691 Fax: 603-228-7087 |